Dendritic cell (DC) vaccines have been demonstrated to elicit immunological responses

Dendritic cell (DC) vaccines have been demonstrated to elicit immunological responses in numerous cancer immunotherapy trials. even further potentiated by addition of the TLR4 agonist LPS. Concurrently, upregulation of the anti-inflammatory cytokine IL-10 was modest. Most importantly, DC matured with IFN, R848, and poly I:C had the ability to activate IFN production in allogeneic T… Continue reading Dendritic cell (DC) vaccines have been demonstrated to elicit immunological responses